News

2024

company

year

domain

Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases

Cellarity, Omega Therapeutics 01.04.2024

Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform

Cellarity 01.04.2024

Loading